Emily Morris serves as Head of Regulatory Affairs and Quality Assurance at Medicines360, where she drives a culture of quality and continuous improvement across the organization and leads the development and execution of regulatory strategies. Since joining the organization in 2012, she has played a key role in advancing product development, regulatory submissions, and post-marketing activities for pharmaceuticals and medical devices across the US and low- and middle-income countries.

Emily scaled the organization’s regulatory affairs function to support expanded global access to the IUD and advance new products designed to address critical unmet needs in women’s health. She is committed to navigating complex regulatory pathways to bring impactful products to market, while ensuring quality compliance during all stages of the product lifecycle.

Emily holds a Master of Science in Regulatory Affairs from Northeastern University and has maintained the Regulatory Affairs Certification in the United States (RAC-US) through the Regulatory Affairs Professionals Society (RAPS) since 2015. She is inspired by Medicines360’s unique model and its commitment to improving women’s health around the world.